21
RAMAN Pattabhi K, ROBINSON Earl T, SIRDESHPANDE Avinash: HYDROMÉTHANISATION DUNE CHARGE CARBONÉE, HYDROMETHANATION OF A CARBONACEOUS FEEDSTOCK. GREATPOINT ENERGY, RAMAN Pattabhi K, ROBINSON Earl T, SIRDESHPANDE Avinash, MIAO Emily, March 15, 2012: WO/2012/033997 (15 worldwide citation)

The present invention relates to processes for hydromethanating a carbonaceous feedstock to a fines-depleted methane-enriched synthesis gas, with recycle of recovered particulate fines back into a specified portion of a hydromethanation reactor.


22

23
MCCLAIN James B, CARLYLE Wenda C, TAYLOR Charles Douglas: FORMES PHARMACEUTIQUES DE TYPE MACROLIDES, MACROLIDE DOSAGE FORMS. MICELL TECHNOLOGIES, MCCLAIN James B, CARLYLE Wenda C, TAYLOR Charles Douglas, WILSON SONSINI GOODRICH & ROSATI, March 15, 2012: WO/2012/034079 (13 worldwide citation)

Provided is a drug delivery composition comprising at least one polymer and at least one active agent; wherein the active agent is present in crystalline form on at least one region of an outer surface of the composition and wherein active agent surface content is adjusted to provide a selected acti ...


24
PENDRI Annapurna, LI Guo, GERRITZ Samuel, LANGLEY David R, TRAINOR George L, MEANWELL Nicholas A: INHIBITEURS DE RÉPLICATION DU VIRUS DU SYNDROME IMMUNODÉFICITAIRE ACQUIS, INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION. BRISTOL MYERS SQUIBB COMPANY, PENDRI Annapurna, LI Guo, GERRITZ Samuel, LANGLEY David R, TRAINOR George L, MEANWELL Nicholas A, EPPERSON James, March 15, 2012: WO/2012/033735 (13 worldwide citation)

The disclosure generally relates to compounds of formula (I), including compositions and methods for treating human immunodeficiency virus (HIV) infection. The disclosure provides novel inhibitors of HIV, pharmaceutical compositions containing such compounds, and methods for using these compounds in ...


25
BRENNER Malcolm, DOTTI Gianpietro, AHMED Nabil, ROSSIG Claudia, GOTTSCHALK Stephen M g, GRADA Zakaria: IMMUNOTHÉRAPIE DES CANCERS UTILISANT DES LYMPHOCYTES T GÉNÉTIQUEMENT MODIFIÉS, SPÉCIFIQUES DE GD2, IMMUNOTHERAPY OF CANCER USING GENETICALLY ENGINEERED GD2-SPECIFIC T CELLS. BAYLOR COLLEGE OF MEDICINE, BRENNER Malcolm, DOTTI Gianpietro, AHMED Nabil, ROSSIG Claudia, GOTTSCHALK Stephen M g, GRADA Zakaria, SISTRUNK Melissa L, March 15, 2012: WO/2012/033885 (12 worldwide citation)

The present invention concerns immunotherapy for cancers having cells that comprise the ganglioside GD2 antigen. In specific embodiment, T cells having a chimeric receptor that targets GD2 is employed. In particular cases, the chimeric receptor comprises antibody, cytoplasmic signaling domain from t ...


26
ZHANG Dong Qing, BHAGAVATHY Sitaram, HE Shan: CODAGE DUNE IMAGE DANS UNE SÉQUENCE VIDÉO POUR UN ÉLAGAGE DE DONNÉES PAR LEXEMPLE À LAIDE DUNE SIMILARITÉ DE CORRECTIFS INTRA-TRAMES, ENCODING OF A PICTURE IN A VIDEO SEQUENCE BY EXAMPLE - BASED DATA PRUNING USING INTRA- FRAME PATCH SIMILARITY. Thomson Licensing, ZHANG Dong Qing, BHAGAVATHY Sitaram, HE Shan, SHEDD Robert D, March 15, 2012: WO/2012/033970 (11 worldwide citation)

Method and apparatus for encoding a picture in video sequence are disclosed. An apparatus includes a library creator (145) for creating a first library from an original version of the picture and a second library from a reconstructed version of the picture. Each library includes high resolution repl ...


27
DWIVEDI Shriprakash Dhar, PATEL Vipul Kantibhai, PANDYA Jayesh Mohanlal: PROCÉDÉ POUR PRÉPARER UN DÉRIVÉ DE BENZOFURANE ET DES PRODUITS INTERMÉDIAIRES DE CELUI-CI, PROCESSES FOR PREPARING DRONEDARONE AND ITS INTERMEDIATES. CADILA HEALTHCARE, DWIVEDI Shriprakash Dhar, PATEL Vipul Kantibhai, PANDYA Jayesh Mohanlal, SUBRAMANIAM Hariharan, March 15, 2012: WO/2012/032545 (10 worldwide citation)

The invention relates to process for the preparation of benzofuran derivative and intermediates thereof. More particularly, it relates to processes for the preparation of dronedarone or pharmaceutically acceptable acid addition salts thereof in crystalline form. The invention also relates to pharmac ...


28
MÜLLER Wilfried: PROCÉDÉ DE FABRICATION DUN MODULE THERMOÉLECTRIQUE, METHOD FOR PRODUCING A THERMOELECTRIC MODULE, VERFAHREN ZUR HERSTELLUNG EINES THERMOELEKTRISCHEN MODULS. EMITEC GESELLSCHAFT FÜR EMISSIONSTECHNOLOGIE MBH, MÜLLER Wilfried, ROESSLER Matthias, March 15, 2012: WO/2012/031980 (10 worldwide citation)

Ein Verfahren zur Herstellung eines thermoelektrischen Moduls ist angegeben, das eine kostengünstige, reproduzierbare und serientaugliche Herstellung eines thermoelektrischen Moduls (1) ermöglicht. Das Verfahren umfasst dabei die Schritte: Abwechselndes Anordnen von zumindest einer Mehrzahl n- und p ...


29

30
FAN Yi, LOREN Jon, MOLTENI Valentina, ALBAUGH Pamela A, CHOPIUK Gregory, SMITH Jeffrey M, FLATT Brenton T: COMPOSÉS ET COMPOSITIONS À TITRE DINHIBITEURS DE TRK, IMIDAZO [1, 2] PYRIDAZIN COMPOUNDS AND COMPOSITIONS AS TRK INHIBITORS. IRM, FAN Yi, LOREN Jon, MOLTENI Valentina, ALBAUGH Pamela A, CHOPIUK Gregory, SMITH Jeffrey M, FLATT Brenton T, RAYMOND Daniel E, March 15, 2012: WO/2012/034091 (9 worldwide citation)

The invention provides compounds of formula (I), pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated TRK kinase activity.



Click the thumbnails below to visualize the patent trend.